Trial Profile
A Double Blind Parallel Group Randomised Multiple Dose Study To Evaluate The Pharmacodynamic Response And Safety Of PHA-794428 In Adult Growth Hormone Deficient Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs PHA 794428 (Primary)
- Indications Somatotropin deficiency
- Focus Pharmacodynamics
- Sponsors Pfizer
- 20 May 2014 New trial record